The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Acute myeloid leukaemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Self-citationCheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Self-citationRecurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Creutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Self-citationDNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,946
Self-citationGrimwade, D., Hills, R. K., Moorman, A. V., Walker, H., Chatters, S., Goldstone, A. H., Wheatley, K., Harrison, C. J., Burnett, A. K., & on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) · Blood · doi:10.1182/blood-2009-11-254441 · Cited by 1,938
Self-citationVariation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,735
Self-citationJordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
Self-citationMutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Self-citationSlovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Byrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,597
Kottaridis, P. D., Gale, R. E., Frew, M. E., Harrison, G., Langabeer, S. E., Belton, A. A., Walker, H., Wheatley, K., Bowen, D. T., Burnett, A. K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1752 · Cited by 1,551
Self-citationIdentification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
Self-citationPrognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Estey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Self-citationKantarjian, H. M., Thomas, X. G., Dmoszynska, A., Wierzbowska, A., Mazur, G., Mayer, J., Gau, J.-P., Chou, W.-C., Buckstein, R., Cermak, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9429 · Cited by 1,169
Dombret, H., Seymour, J. F., Butrym, A., Wierzbowska, A., Selleslag, D., Jang, J. H., Kumar, R., Cavenagh, J., Schuh, A. C., Candoni, A., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621664 · Cited by 1,165
Dnmt3a is essential for hematopoietic stem cell differentiation
Challen, G. A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J. S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.1009 · Cited by 1,122
Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia
Bullinger, L., Döhner, K., Bair, E., Fröhling, S., Schlenk, R. F., Tibshirani, R., Döhner, H., & Pollack, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031046 · Cited by 993
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
Lindsley, R. C., Mar, B. G., Mazzola, E., Grauman, P. V., Shareef, S., Allen, S. L., Pigneux, A., Wetzler, M., Stuart, R. K., Erba, H. P., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610543 · Cited by 991
Juliusson, G., Antunovic, P., Derolf, Å., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A., & Höglund, M. (2009) · Blood · doi:10.1182/blood-2008-07-172007 · Cited by 987
Fenaux, P., Mufti, G. J., Hellström-Lindberg, E., Santini, V., Gattermann, N., Germing, U., Sanz, G., List, A. F., Gore, S., Seymour, J. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8329 · Cited by 961
Sanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Self-citationKoreth, J., Schlenk, R., Kopecky, K. J., Honda, S., Sierra, J., Djulbegovic, B. J., Wadleigh, M., DeAngelo, D. J., Stone, R. M., Sakamaki, H., et al. (2009) · JAMA · doi:10.1001/jama.2009.813 · Cited by 886
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Bernt, K. M., Zhu, N., Sinha, A. U., Vempati, S., Faber, J., Krivtsov, A. V., Feng, Z., Punt, N., Daigle, A., Bullinger, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.010 · Cited by 870
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Assessment of Minimal Residual Disease in Standard-Risk AML
Ivey, A., Hills, R. K., Simpson, M. A., Jovanovic, J. V., Gilkes, A., Grech, A., Patel, Y., Bhudia, N., Farah, H., Mason, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507471 · Cited by 845
Self-citationDNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P. J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.020 · Cited by 833
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007) · Science · doi:10.1126/science.1142596 · Cited by 827
Therapeutic Advances in Acute Myeloid Leukemia
Burnett, A., Wetzler, M., & Löwenberg, B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1820 · Cited by 787
Self-citationMarcucci, G., Maharry, K., Wu, Y.-Z., Radmacher, M. D., Mrózek, K., Margeson, D., Holland, K. B., Whitman, S. P., Becker, H., Schwind, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3730 · Cited by 763
Self-citationNuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Self-citationGale, R. E., Green, C., Allen, C., Mead, A. J., Burnett, A. K., Hills, R. K., & Linch, D. C. (2008) · Blood · doi:10.1182/blood-2007-08-109090 · Cited by 745
Self-citationGross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736
Hills, R. K., Castaigne, S., Appelbaum, F. R., Delaunay, J., Petersdorf, S., Othus, M., Estey, E. H., Dombret, H., Chevret, S., Ifrah, N., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70281-5 · Cited by 721
Self-citationGuzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Self-citationDores, G. M., Devesa, S. S., Curtis, R. E., Linet, M. S., & Morton, L. M. (2012) · Blood · doi:10.1182/blood-2011-04-347872 · Cited by 636
Burnett, A. K., Milligan, D., Prentice, A. G., Goldstone, A. H., McMullin, M. F., Hills, R. K., & Wheatley, K. (2007) · Cancer · doi:10.1002/cncr.22496 · Cited by 619
Self-citationASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Abdel-Wahab, O., Adli, M., LaFave, L. M., Gao, J., Hricik, T., Shih, A. H., Pandey, S., Patel, J. P., Chung, Y. R., Koche, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.032 · Cited by 599
Self-citationWouters, B. J., Löwenberg, B., Erpelinck-Verschueren, C. A. J., van Putten, W. L. J., Valk, P. J. M., & Delwel, R. (2009) · Blood · doi:10.1182/blood-2008-09-179895 · Cited by 566
Burnett, A. K., Goldstone, A. H., Stevens, R. M., Hann, I. M., Rees, J. K., Gray, R. G., & Wheatley, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09214-3 · Cited by 563
Self-citationJin, L., Lee, E. M., Ramshaw, H. S., Busfield, S. J., Peoppl, A. G., Wilkinson, L., Guthridge, M. A., Thomas, D., Barry, E. F., Boyd, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.04.018 · Cited by 522
Proposals for the immunological classification of acute leukemias.
Paietta, E. M. (1995) · PubMed · Cited by 503
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Self-citationFLT3: ITDoes matter in leukemia
Levis, M., & Small, D. (2003) · Leukemia · doi:10.1038/sj.leu.2403099 · Cited by 495
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
de Thé, H., & Chen, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2943 · Cited by 488
Gamis, A. S., Alonzo, T. A., Meshinchi, S., Sung, L., Gerbing, R. B., Raimondi, S. C., Hirsch, B. A., Kahwash, S. B., Heerema-McKenney, A., Winter, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3628 · Cited by 486
Engineering CAR-T cells: Design concepts
Srivastava, S., & Riddell, S. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.004 · Cited by 485
Cornelissen, J. J., van Putten, W. L. J., Verdonck, L. F., Theobald, M., Jacky, E., Daenen, S. M. G., van Marwijk Kooy, M., Wijermans, P., Schouten, H., Huijgens, P. C., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025627 · Cited by 471
Self-citationImatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 470
Terwijn, M., van Putten, W. L. J., Kelder, A., van der Velden, V. H. J., Brooimans, R. A., Pabst, T., Maertens, J., Boeckx, N., de Greef, G. E., Valk, P. J. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9628 · Cited by 442
Sorror, M. L., Storb, R. F., Sandmaier, B. M., Maziarz, R. T., Pulsipher, M. A., Maris, M. B., Bhatia, S., Ostronoff, F., Deeg, H. J., Syrjala, K. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.8157 · Cited by 423
Self-citationWang, Q.-S., Wang, Y., Lv, H.-Y., Han, Q.-W., Fan, H., Guo, B., Wang, L.-L., & Han, W.-D. (2015) · Molecular Therapy · doi:10.1038/mt.2014.164 · Cited by 418
Cytarabine Dose for Acute Myeloid Leukemia
Löwenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Biemond, B. J., Gratwohl, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010222 · Cited by 407
Mrózek, K., Marcucci, G., Nicolet, D., Maharry, K. S., Becker, H., Whitman, S. P., Metzeler, K. H., Schwind, S., Wu, Y.-Z., Kohlschmidt, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4738 · Cited by 406
Self-citationCornelissen, J. J., Gratwohl, A., Schlenk, R. F., Sierra, J., Bornhäuser, M., Juliusson, G., Råcil, Z., Rowe, J. M., Russell, N., Mohty, M., et al. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.150 · Cited by 400
Self-citationSarry, J.-E., Murphy, K., Perry, R., Sanchez, P. V., Secreto, A., Keefer, C., Swider, C. R., Strzelecki, A.-C., Cavelier, C., Récher, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41495 · Cited by 386
Gratwohl, A., Stern, M., Brand, R., Apperley, J., Baldomero, H., de Witte, T., Dini, G., Rocha, V., Passweg, J., Sureda, A., et al. (2009) · Cancer · doi:10.1002/cncr.24531 · Cited by 379
Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D. J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S. G., et al. (2008) · Blood · doi:10.1182/blood-2007-10-118331 · Cited by 373
Modeling the Initiation and Progression of Human Acute Leukemia in Mice
Barabé, F., Kennedy, J. A., Hope, K. J., & Dick, J. E. (2007) · Science · doi:10.1126/science.1139851 · Cited by 349
Klco, J. M., Miller, C. A., Griffith, M., Petti, A., Spencer, D. H., Ketkar-Kulkarni, S., Wartman, L. D., Christopher, M., Lamprecht, T. L., Helton, N. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.9643 · Cited by 339
Sorror, M. L., Giralt, S., Sandmaier, B. M., De Lima, M., Shahjahan, M., Maloney, D. G., Deeg, H. J., Appelbaum, F. R., Storer, B., & Storb, R. (2007) · Blood · doi:10.1182/blood-2007-06-096966 · Cited by 326
Acute myeloid leukemia in the real world: why population-based registries are needed
Juliusson, G., Lazarevic, V., Hörstedt, A.-S., Hagberg, O., & Höglund, M. (2012) · Blood · doi:10.1182/blood-2011-12-379008 · Cited by 305
Antileukemic activity of rapamycin in acute myeloid leukemia
Récher, C., Beyne-Rauzy, O., Demur, C., Chicanne, G., Dos Santos, C., Mas, V. M.-D., Benzaquen, D., Laurent, G., Huguet, F., & Payrastre, B. (2005) · Blood · doi:10.1182/blood-2004-06-2494 · Cited by 296
Sant, M., Minicozzi, P., Mounier, M., Anderson, L. A., Brenner, H., Holleczek, B., Marcos-Gragera, R., Maynadié, M., Monnereau, A., Osca-Gelis, G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70282-7 · Cited by 291
Giles, F. J., Kantarjian, H. M., Kornblau, S. M., Thomas, D. A., Garcia-Manero, G., Waddelow, T. A., David, C. L., Phan, A. T., Colburn, D. E., Rashid, A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2<406::aid-cncr1336>3.0.co;2-u · Cited by 283
Self-citationMetzeler, K. H., Maharry, K., Radmacher, M. D., Mrózek, K., Margeson, D., Becker, H., Curfman, J., Holland, K. B., Schwind, S., Whitman, S. P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.7742 · Cited by 280
Self-citationAcute myeloid leukemia: 2013 update on risk‐stratification and management
Estey, E. H. (2013) · American Journal of Hematology · doi:10.1002/ajh.23404 · Cited by 277
Self-citationRosenblat, T. L., McDevitt, M. R., Mulford, D. A., Pandit-Taskar, N., Divgi, C. R., Panageas, K. S., Heaney, M. L., Chanel, S., Morgenstern, A., Sgouros, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0382 · Cited by 271
Self-citationGrimwade, D., & Freeman, S. D. (2014) · Blood · doi:10.1182/blood-2014-05-577593 · Cited by 262
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
Sato, T., Yang, X., Knapper, S., White, P., Smith, B. D., Galkin, S., Small, D., Burnett, A., & Levis, M. (2011) · Blood · doi:10.1182/blood-2010-01-266742 · Cited by 261
Self-citationRampal, R., Alkalin, A., Madzo, J., Vasanthakumar, A., Pronier, E., Patel, J., Li, Y., Ahn, J., Abdel-Wahab, O., Shih, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.004 · Cited by 261
Self-citationLandgren, O., Goldin, L. R., Kristinsson, S. Y., Helgadottir, E. A., Samuelsson, J., & Björkholm, M. (2008) · Blood · doi:10.1182/blood-2008-03-143602 · Cited by 261
Chen, X., Xie, H., Wood, B. L., Walter, R. B., Pagel, J. M., Becker, P. S., Sandhu, V. K., Abkowitz, J. L., Appelbaum, F. R., & Estey, E. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3518 · Cited by 257
Self-citationKeeton, E. K., McEachern, K., Dillman, K. S., Palakurthi, S., Cao, Y., Grondine, M. R., Kaur, S., Wang, S., Chen, Y., Wu, A., et al. (2014) · Blood · doi:10.1182/blood-2013-04-495366 · Cited by 254
Adès, L., Guerci, A., Raffoux, E., Sanz, M., Chevallier, P., Lapusan, S., Recher, C., Thomas, X., Rayon, C., Castaigne, S., et al. (2010) · Blood · doi:10.1182/blood-2009-07-233387 · Cited by 251
Acquired copy number alterations in adult acute myeloid leukemia genomes
Walter, M. J., Payton, J. E., Ries, R. E., Shannon, W. D., Deshmukh, H., Zhao, Y., Baty, J., Heath, S., Westervelt, P., Watson, M. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903091106 · Cited by 246
Self-citationSujobert, P. (2005) · Blood · doi:10.1182/blood-2004-08-3225 · Cited by 245
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice
Schessl, C., Rawat, V. P. S., Cusan, M., Deshpande, A., Kohl, T. M., Rosten, P. M., Spiekermann, K., Humphries, R. K., Schnittger, S., Kern, W., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24225 · Cited by 237
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
Gjertsen, B. T., & Schöffski, P. (2015) · Leukemia · doi:10.1038/leu.2014.222 · Cited by 222
Virappane, P., Gale, R., Hills, R., Kakkas, I., Summers, K., Stevens, J., Allen, C., Green, C., Quentmeier, H., Drexler, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0333 · Cited by 218
Self-citationLeukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
Terwijn, M., Zeijlemaker, W., Kelder, A., Rutten, A. P., Snel, A. N., Scholten, W. J., Pabst, T., Verhoef, G., Löwenberg, B., Zweegman, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107587 · Cited by 215
Sekeres, M. A., Stone, R. M., Zahrieh, D., Neuberg, D., Morrison, V, De Angelo, D. J., Galinsky, I., & Lee, S. J. (2004) · Leukemia · doi:10.1038/sj.leu.2403289 · Cited by 208
Survival and cure of acute myeloid leukaemia in England, 1971‐2006: a population–based study
Shah, A., Andersson, T. M. ‐., Rachet, B., Björkholm, M., & Lambert, P. C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12425 · Cited by 206
Eghtedar, A., Verstovsek, S., Estrov, Z., Burger, J., Cortes, J., Bivins, C., Faderl, S., Ferrajoli, A., Borthakur, G., George, S., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400051 · Cited by 200
Acute Myeloid Leukemia Stem Cells
DICK, J. E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.001 · Cited by 189
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
Dao, T., Yan, S., Veomett, N., Pankov, D., Zhou, L., Korontsvit, T., Scott, A., Whitten, J., Maslak, P., Casey, E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005661 · Cited by 181
Self-citationIndependent prognostic factors for AML outcome
Grimwade, D., & Hills, R. K. (2009) · Hematology · doi:10.1182/asheducation-2009.1.385 · Cited by 180
Maurillo, L., Buccisano, F., Del Principe, M. I., Del Poeta, G., Spagnoli, A., Panetta, P., Ammatuna, E., Neri, B., Ottaviani, L., Sarlo, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9814 · Cited by 179
Morrison, V. A., Rai, K. R., Peterson, B. L., Kolitz, J. E., Elias, L., Appelbaum, F. R., Hines, J. D., Shepherd, L., Larson, R. A., & Schiffer, C. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.128 · Cited by 176
Walter, R. B., Othus, M., Burnett, A. K., Löwenberg, B., Kantarjian, H. M., Ossenkoppele, G. J., Hills, R. K., Ravandi, F., Pabst, T., Evans, A., et al. (2015) · Leukemia · doi:10.1038/leu.2014.242 · Cited by 170
Self-citationOthus, M., Kantarjian, H., Petersdorf, S., Ravandi, F., Godwin, J., Cortes, J., Pierce, S., Erba, H., Faderl, S., Appelbaum, F. R., et al. (2014) · Leukemia · doi:10.1038/leu.2013.176 · Cited by 167
Self-citationSense and nonsense of high-dose cytarabine for acute myeloid leukemia
Löwenberg, B. (2013) · Blood · doi:10.1182/blood-2012-07-444851 · Cited by 165
Chapuis, N., Tamburini, J., Green, A. S., Vignon, C., Bardet, V., Neyret, A., Pannetier, M., Willems, L., Park, S., Macone, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1102 · Cited by 164
Self-citationSYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia
Puissant, A., Fenouille, N., Alexe, G., Pikman, Y., Bassil, C. F., Mehta, S., Du, J., Kazi, J. U., Luciano, F., Rönnstrand, L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.022 · Cited by 162
Burnett, A. K., Hills, R. K., Hunter, A. E., Milligan, D., Kell, W. J., Wheatley, K., Yin, J., McMullin, M. F., Dignum, H., Bowen, D., et al. (2013) · Leukemia · doi:10.1038/leu.2012.229 · Cited by 161
Self-citationJurcic, J. G., DeBlasio, T., Dumont, L., Yao, T., & Scheinberg, D. A. (2000) · PubMed · Cited by 159
Self-citationStone, R. M., Mandrekar, S., Sanford, B. L., Geyer, S., Bloomfield, C. D., Dohner, K., Thiede, C., Marcucci, G., Lo-Coco, F., Klisovic, R. B., et al. (2015) · Blood · doi:10.1182/blood.v126.23.6.6 · Cited by 159
Self-citationGreif, P. A., Dufour, A. M., Konstandin, N. P., Ksienzyk, B., Zellmeier, E., Tizazu, B., Sturm, J., Benthaus, T., Herold, T., Yaghmaie, M., et al. (2012) · Blood · doi:10.1182/blood-2012-01-403220 · Cited by 158
FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance
Grunwald, M. R., & Levis, M. J. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1334-8 · Cited by 157
Epidemiology of childhood acute myeloid leukemia
Puumala, S. E., Ross, J. A., Aplenc, R., & Spector, L. G. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24464 · Cited by 154
Gardner, A., Mattiuzzi, G. N., Faderl, S. H., Borthakur, G. M., Garcia‐Manero, G., Pierce, S. A., Brandt, M., & Estey, E. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4681 · Cited by 152
Self-citationKäyser, S., Zucknick, M., Döhner, K., Krauter, J., Köhne, C., Horst, H. A., Held, G., von Lilienfeld‐Toal, M., Wilhelm, S., Rummel, M., et al. (2011) · Blood · doi:10.1182/blood-2011-07-367508 · Cited by 150
Friedrich, M., Henn, A., Raum, T., Bajtus, M., Matthes, K., Hendrich, L., Wahl, J., Hoffmann, P., Kischel, R., Kvesic, M., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0956 · Cited by 148
Holz-Schietinger, C., Matje, D. M., & Reich, N. O. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366625 · Cited by 146
Cornelissen, J. J., Breems, D. A., van Putten, W. L. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6499 · Cited by 139
Self-citationGrisolano, J. L., O’Neal, J., Cain, J., & Tomasson, M. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531730100 · Cited by 135
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
Vellenga, E., van Putten, W., Ossenkoppele, G. J., Verdonck, L. F., Theobald, M., Cornelissen, J. J., Huijgens, P. C., Maertens, J. A., Gratwohl, A. A., Schaafsma, R., et al. (2011) · Blood · doi:10.1182/blood-2011-07-370247 · Cited by 134
Self-citationBurnett, A. K., Russell, N. H., Hunter, A., Milligan, D. W., Knapper, S., Wheatley, K., Yin, J., McMullin, M. F., Ali, S., Bowen, D., et al. (2013) · Blood · doi:10.1182/blood-2013-04-496596 · Cited by 132
Self-citationCornelissen, J. J., Versluis, J., Passweg, J. R., van Putten, W. L. J., Manz, M. G., Maertens, J. A., Beverloo, H. B., Valk, P. J. M., Kooy, M. V. M., Wijermans, P., et al. (2014) · Leukemia · doi:10.1038/leu.2014.332 · Cited by 131
Self-citationDerolf, Å. R., Kristinsson, S. Y., Andersson, T., Landgren, O., Dickman, P. W., & Björkholm, M. (2008) · Blood · doi:10.1182/blood-2008-09-179341 · Cited by 129
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
Luskin, M. R., Lee, J., Fernandez, H. F., Abdel-Wahab, O. I., Bennett, J. M., Ketterling, R. P., Lazarus, H. M., Levine, R. L., Litzow, M. R., Paietta, E. M., et al. (2016) · Blood · doi:10.1182/blood-2015-07-657403 · Cited by 128
Self-citationImpact of FLT3ITD mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia
Linch, D. C., Hills, R. K., Burnett, A. K., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554667 · Cited by 122
Self-citationJain, N., Curran, E. K., Iyengar, N. M., Díaz-Flores, E., Kunnavakkam, R., Popplewell, L. L., Kirschbaum, M. H., Karrison, T., Erba, H. P., Green, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1311 · Cited by 122
Сергеева, А., Alatrash, G., He, H., Ruisaard, K. E., Lu, S., Wygant, J. N., McIntyre, B. W., Ma, Q., Li, D., John, L. S. S., et al. (2011) · Blood · doi:10.1182/blood-2010-07-299248 · Cited by 120
Identification of Bruton’s tyrosine kinase as a therapeutic target in acute myeloid leukemia
Rushworth, S. A., Murray, M. Y., Zaitseva, L., Bowles, K. M., & MacEwan, D. J. (2013) · Blood · doi:10.1182/blood-2013-06-511154 · Cited by 120
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
García, P. D., Langowski, J. L., Wang, Y., Chen, M., Castillo, J., Fanton, C. P., Ison-Dugenny, M., Zavorotinskaya, T., Dai, Y., Lü, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2062 · Cited by 119
Preclinical efficacy of MEK inhibition in Nras-mutant AML
Burgess, M. R., Hwang, E., Firestone, A. J., Huang, T. Q., Xu, J., Zuber, J. A., Bohin, N., Wen, T., Kogan, S. C., Haigis, K. M., et al. (2014) · Blood · doi:10.1182/blood-2014-05-574582 · Cited by 118
Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia
Sanz, M. Á., Tallman, M. S., & Lo‐Coco, F. (2004) · Blood · doi:10.1182/blood-2004-09-3475 · Cited by 116
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia
Sujobert, P., Poulain, L., Paubelle, E., Zylbersztejn, F., Grenier, A., Lambert, M., Townsend, E. C., Brusq, J.-M., Nicodeme, E., Decrooqc, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.063 · Cited by 114
Self-citationMonitoring of minimal residual disease in acute myeloid leukemia
Kern, W., Haferlach, C., Haferlach, T., & Schnittger, S. (2007) · Cancer · doi:10.1002/cncr.23128 · Cited by 112
Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia
Grimwade, D. J., & Mrózek, K. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.09.018 · Cited by 108
Carney, D. A., Westerman, D., Tam, C. S. L., Milner, A., Prince, H. M., Kenealy, M. K., Wolf, M., Januszewicz, E. H., Ritchie, D., Came, N. A., et al. (2010) · Leukemia · doi:10.1038/leu.2010.218 · Cited by 107
Stelljes, M., Krug, U. O., Beelen, D. W., Braess, J., Sauerland, M. C., Heinecke, A., Ligges, S., Sauer, T., Tschanter, P., Thoennissen, G. B., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.5768 · Cited by 106
Pulte, D. D., Redaniel, M. T., Jansen, L., Brenner, H., & Jeffreys, M. (2012) · Haematologica · doi:10.3324/haematol.2012.063602 · Cited by 104
Moore, A. S., Blagg, J., Linardopoulos, S., et al. (2010) · Leukemia · doi:10.1038/leu.2010.15 · Cited by 96
Treatment of acute myeloid leukemia: are we making progress?
Burnett, A. K. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.1.3797038 · Cited by 95
Self-citationLeukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
Greiner, J., Bullinger, L., Guinn, B., Döhner, H., & Schmitt, M. W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1102 · Cited by 93
Gale, R. E., Lamb, K., Allen, C. G., El‐Sharkawi, D., Stowe, C., Jenkinson, S., Tinsley, S., Dickson, G. J., Burnett, A. K., Hills, R. K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.2022 · Cited by 92
Self-citationMolecular biology of acute myeloid leukemia.
Caligiuri, M. A., Strout, M. P., & Gilliland, D. G. (1997) · PubMed · Cited by 91
Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid Leukemia
Freeman, S. D., Jovanovic, J. V., & Grimwade, D. J. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.009 · Cited by 90
Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis
Seif, A. E. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.04.005 · Cited by 89
Molecular Pathways: Targeting NRAS in Melanoma and Acute Myelogenous Leukemia
Johnson, D. B., Smalley, K. S. M., & Sosman, J. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3270 · Cited by 87
Lima, M. J. G. D., Strom, S. S., Keating, M. J., et al. (1997) · Blood · doi:10.1182/blood.v90.12.4719 · Cited by 84
Versluis, J., Labopin, M., Niederwieser, D. W., Socié, G., Schlenk, R. F., Milpied, N. J., Nagler, A., Blaise, D., Rocha, V., Cornelissen, J. J., et al. (2014) · Leukemia · doi:10.1038/leu.2014.164 · Cited by 81
Self-citationApplicability of a “Pick a Winner” trial design to acute myeloid leukemia
Hills, R. K., & Burnett, A. K. (2011) · Blood · doi:10.1182/blood-2011-02-337261 · Cited by 79
Self-citationUnderreporting of Myeloid Malignancies by United States Cancer Registries
Craig, B. M., Rollison, D. E. M., List, A. F., & Cogle, C. R. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1087 · Cited by 76
Targeting FLT3 to treat leukemia
Koenig, H., & Levis, M. J. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.960843 · Cited by 72
Stein, E. M., Dinardo, C. D., Altman, J. K., Collins, R. H., DeAngelo, D. J., Kantarjian, H. M., Sekeres, M. A., Fathi, A. T., Flinn, I. W., Frankel, A. E., et al. (2015) · Blood · doi:10.1182/blood.v126.23.323.323 · Cited by 72
Self-citationSinha, S., Thomas, D., Yu, L. C., Gentles, A. J., Jung, N., Corces, M. R., Chan, S. M., Reinisch, A., Feinberg, A. P., Dill, D. L., et al. (2014) · Blood · doi:10.1182/blood-2014-03-566018 · Cited by 64
Lazarević, V., Hörstedt, A.-S., Johansson, B., Antunović, P., Billström, R., Derolf, Å. R., Hulegårdh, E., Lehmann, S., Möllgård, L., Nilsson, C. C., et al. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.10 · Cited by 62
Sehgal, A. R., Gimotty, P. A., Zhao, J., Hsu, J., Daber, R. D., Morrissette, J. D., Luger, S. M., Loren, A. W., & Carroll, M. P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0327 · Cited by 61
Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation
Mohty, M., & Apperley, J. F. (2010) · Hematology · doi:10.1182/asheducation-2010.1.229 · Cited by 59
Burnett, A. K., Russell, N. H., Culligan, D. J., Cavanagh, J. D., Kell, J., Wheatley, K., Virchis, A., Hills, R. K., & Milligan, D. W. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09165.x · Cited by 56
Self-citationHematopoietic Stem Cells Are Intrinsically Protected against MLL-ENL-Mediated Transformation
Ugale, A. S., Norddahl, G. L., Wahlestedt, M., Säwén, P., Jaako, P., Pronk, C. J., Soneji, S., Cammenga, J., & Bryder, D. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.036 · Cited by 53
Dubrovsky, L., Pankov, D., Brea, E. J., et al. (2014) · Blood · doi:10.1182/blood-2014-01-549022 · Cited by 52
The biology and clinical impact of genetic lesions in myeloid malignancies
Lindsley, R. C., & Ebert, B. L. (2013) · Blood · doi:10.1182/blood-2013-06-460295 · Cited by 50
Chemotherapy resistance in acute myeloid leukaemia
Sonneveld, P., & List, A. F. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0124 · Cited by 50
Dennis, M., Russell, N. H., Hills, R. K., Hemmaway, C. J., Panoskaltsis, N., McMullin, M., Kjeldsen, L., Dignum, H., Thomas, I., Clark, R. E., et al. (2015) · Blood · doi:10.1182/blood-2014-10-608117 · Cited by 48
Self-citationBarba, P., Martino, R., Pérez‐Simón, J. A., Fernández‐Avilés, F., Castillo, N., Piñana, J. L., López‐Anglada, L., Rovira, M., Bosch, F., Carreras, E., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.10.011 · Cited by 48
Familial Aggregation of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Goldin, L. R., Kristinsson, S. Y., Liang, X. S., Derolf, Å. R., Landgren, O., & Björkholm, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1203 · Cited by 42
Minimal residual disease–directed therapy in acute myeloid leukemia
Käyser, S., Schlenk, R. F., Grimwade, D. J., et al. (2015) · Blood · doi:10.1182/blood-2014-11-578815 · Cited by 40
Gene-Expression Profiling in Acute Myeloid Leukemia
Grimwade, D. J., & Haferlach, T. (2004) · New England Journal of Medicine · doi:10.1056/nejme048040 · Cited by 39
Burnett, A. K., Russell, N. H., Hills, R. K., Panoskaltsis, N., Khwaja, A., Hemmaway, C. J., Cahalin, P. A., Clark, R. E., & Milligan, D. W. (2015) · Leukemia · doi:10.1038/leu.2015.38 · Cited by 37
Self-citationTherapy-Related Myeloid Neoplasms
Bueso-Ramos, C., Kanagal‐Shamanna, R., Routbort, M. J., & Hanson, C. A. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpu1jo2lytwuav · Cited by 32
Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia
Medeiros, B. C., Othus, M. K. D., Fang, M., Appelbaum, F. R., & Erba, H. P. (2014) · Haematologica · doi:10.3324/haematol.2014.117267 · Cited by 29
Assessment of Minimal Residual Disease in Standard-Risk AML.
Hills, R. K., Ivey, A., & Grimwade, D. J. (2016) · PubMed · doi:10.1056/nejmc1603847 · Cited by 27
Next Generation Sequencing Methodologies - An Overview
Pickrell, W. O., Rees, M. I., & Chung, S. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-394287-6.00001-x · Cited by 24
Neutropenic Fever and Sepsis: Evaluation and Management
Rolston, K. V. I. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_6 · Cited by 21
Score, J., Chase, A., Forsberg, L. A., Feng, L., Waghorn, K., Jones, A. V., Rasi, C., Linch, D. C., Dumanski, J. P., Gale, R. E., et al. (2015) · Leukemia · doi:10.1038/leu.2015.13 · Cited by 18
Self-citationIacobucci, I., Lonetti, A., Papayannidis, C., & Martinelli, G. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990089 · Cited by 10
Shenoi, J., Gopal, A. K., Press, O. W., & Pagel, J. M. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328335ccc2 · Cited by 4
Cited by
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationClonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia
Jan, M., Snyder, T. M., Corces-Zimmerman, M. R., Vyas, P., Weissman, I. L., Quake, S. R., & Majeti, R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004315 · Cited by 721
Corces-Zimmerman, M. R., Hong, W.-J., Weissman, I. L., Medeiros, B. C., & Majeti, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324297111 · Cited by 705
Creutzig, U., van den Heuvel-Eibrink, M. M., Gibson, B., Dworzak, M. N., Adachi, S., de Bont, E., Harbott, J., Hasle, H., Johnston, D., Kinoshita, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-362608 · Cited by 577
The leukemic stem cell niche: current concepts and therapeutic opportunities
Lane, S. W., Scadden, D. T., & Gilliland, D. G. (2009) · Blood · doi:10.1182/blood-2009-01-202606 · Cited by 461
Metadata
- Authors
- Khwaja, A., Bjorkholm, M., Gale, R. E., Levine, R. L., Jordan, C. T., Ehninger, G., Bloomfield, C. D., Estey, E., Burnett, A., Cornelissen, J. J., Scheinberg, D. A., Bouscary, D., & Linch, D. C.
- Venue
- Nature Reviews Disease Primers
- Published
- 2016-03-10
- Volume
- 2
- Issue
- 1
- Pages
- 16010-16010
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2523562238
- Cited by
- 592
- References
- 184
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.